Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP Block in Breast Cancer Surgery
NCT04726878Phase 4Completed
- Sponsor
- Medical University of Lublin
- Start
- Feb 2021
- Primary completion
- Aug 2021
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in pain, sponsored by Medical University of Lublin. Started Feb 2021; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
pain
Beyond the preview
Go deeper on NCT04726878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04726878.